Leona Gabryšová

Leona Gabryšová

Auto-generated profile, based on publicly available information

Leona Gabryšová

The Francis Crick Institute, Laboratory of Immunoregulation and Infection, London, UK

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 August 2012 in European Journal of Immunology
Verified
Journal Article
Open access
PDF file
ZUZoë Urry
Zoë Urry
ECEmma S. Chambers
Emma S. Chambers
EXEmmanuel Xystrakis
Emmanuel Xystrakis
SDSarah Dimeloe
Sarah Dimeloe
DRDavid F. Richards
David F. Richards
CHCatherine Hawrylowicz
Catherine Hawrylowicz
1α,25‐Dihydroxyvitamin D3 (1α25VitD3) has potent immunomodulatory properties. We have previously demonstrated that 1α25VitD3 promotes human and murine IL‐10‐secreting CD4+ T cells. Because of the clinical relevance of this observation, we characterized these cells further and investigated their relationship with Foxp3+ regulatory T (Treg) cells. 1α25VitD3 increased the frequency of both Foxp3+ and IL‐10+ CD4+T cells in vitro. However, Foxp3 was increased at high concentrations of 1α25VitD3 and IL‐10 at more moderate levels, with little coexpression of these molecules. The Foxp3+ and IL‐10+ T‐cell populations showed comparable suppressive activity. We demonstrate that the enhancement of Foxp3 expression by 1α25VitD3 is impaired by IL‐10. 1α25VitD3 enables the selective expansion of Foxp3+ Treg cells over their Foxp3− T‐cell counterparts. Equally, 1α25VitD3 maintains Foxp3+ expression by sorted populations of human and murine Treg cells upon in vitro culture. A positive in vivo correlation between vitamin D status and CD4+Foxp3+ T cells in the airways was observed in a severe pediatric asthma cohort, supporting the in vitro observations. In summary, we provide evidence that 1α25VitD3 enhances the frequency of both IL‐10+ and Foxp3+ Treg cells. In a translational setting, these data suggest that 1α25VitD3, over a broad concentration range, will be effective in enhancing the frequency of Treg cells.

27 July 2009 in Journal of Experimental Medicine
Verified
Journal Article
Open access
LGLeona Gabryšová
Leona Gabryšová
KNKirsty S. Nicolson
Kirsty S. Nicolson
HSHeather B. Streeter
Heather B. Streeter
JVJohan Verhagen
Johan Verhagen
CSCatherine A. Sabatos-Peyton
Catherine A. Sabatos-Peyton
DWDavid C. Wraith
David C. Wraith
Regulation of the immune response to self- and foreign antigens is vitally important for limiting immune pathology associated with both infections and hypersensitivity conditions. Control of autoimmune conditions can be reinforced by tolerance induction with peptide epitopes, but the mechanism is not currently understood. Repetitive intranasal administration of soluble peptide induces peripheral tolerance in myelin basic protein (MBP)–specific TCR transgenic mice. This is characterized by the presence of anergic, interleukin (IL)-10–secreting CD4+ T cells with regulatory function (IL-10 T reg cells). The differentiation pathway of peptide-induced IL-10 T reg cells was investigated. CD4+ T cells became anergic after their second encounter with a high-affinity MBP peptide analogue. Loss of proliferative capacity correlated with a switch from the Th1-associated cytokines IL-2 and interferon (IFN)-γ to the regulatory cytokine IL-10. Nevertheless, IL-10 T reg cells retained the capacity to produce IFN-γ and concomitantly expressed T-bet, demonstrating their Th1 origin. IL-10 T reg cells suppressed dendritic cell maturation, prevented Th1 cell differentiation, and thereby created a negative feedback loop for Th1-driven immune pathology. These findings demonstrate that Th1 responses can be self-limiting in the context of peripheral tolerance to a self-antigen.

16 April 2018 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
LGLeona Gabryšová
Leona Gabryšová
MAMarisol Alvarez-Martinez
Marisol Alvarez-Martinez
RLRaphaëlle Luisier
Raphaëlle Luisier
LCLuke S. Cox
Luke S. Cox
JSJan Sodenkamp
Jan Sodenkamp
AOAnne O’gArra
Anne O’gArra

9 July 2014
Verified
Book Chapter
Closed access
PDF file
LGLeona Gabryšová
Leona Gabryšová
AHAshleigh Howes
Ashleigh Howes
MSMargarida Saraiva
Margarida Saraiva
AOAnne O’gArra
Anne O’gArra

23 September 2011 in Nature Reviews Immunology
Verified
Journal Article
Closed access
PDF file
RMRuslan Medzhitov
Ruslan Medzhitov
Ethan ShevachEthan Shevach
Ethan Shevach
GTGiorgio Trinchieri
Giorgio Trinchieri
AMAndrew L. Mellor
Andrew L. Mellor
DMDavid H. Munn
David H. Munn
AOAnne O'GArra
Anne O'GArra

24 February 2011 in European Journal of Immunology
Verified
Journal Article
Open access
PDF file
LGLeona Gabryšová
Leona Gabryšová
JCJillian R. Christensen
Jillian R. Christensen
XWXuemei Wu
Xuemei Wu
AKAdrien Kissenpfennig
Adrien Kissenpfennig
BMBernard Malissen
Bernard Malissen
AOAnne O'GArra
Anne O'GArra
Foxp3‐expressing Tregs play a non‐redundant role in protecting against immune pathologies. Foxp3+ Tregs can arise intra‐ and extra‐thymically, however, the signals directing their differentiation and maintenance in the periphery are not well understood. We show that stimulation of mouse naïve CD4+ T cells in vitro with optimal doses of anti‐CD3/anti‐CD28 resulted in high frequencies of Foxp3+ T cells via a TGF‐β‐dependent mechanism. Addition of TGF‐β and retinoic acid overcame the inhibition of Foxp3 expression observed during high‐strength anti‐CD3/anti‐CD28 stimulation. Reducing the strength of TCR or costimulatory signals with inhibitors of mammalian target of rapamycin (mTOR) or MEK/ERK signalling also enhanced expression of Foxp3 in a TGF‐β‐dependent manner. Addition of TGF‐β was further required to maintain Foxp3 expression in ex vivo derived Foxp3+ Tregs upon prolonged anti‐CD3/anti‐CD28 signalling. Thus, induction/maintenance of Foxp3 expression by TGF‐β is modulated by the integrated strength of TCR/costimulatory signals.